FY2025 EPS Forecast for The Cigna Group Boosted by Analyst

The Cigna Group (NYSE:CI) – Analysts at Cantor Fitzgerald raised their FY2025 EPS estimates for shares of The Cigna Group in a research report issued to clients and investors on Sunday, May 4th. Cantor Fitzgerald analyst S. James now forecasts that the health services provider will post earnings of $29.66 per share for the year, up from their prior estimate of $29.61. Cantor Fitzgerald currently has a “Overweight” rating and a $365.00 price target on the stock. The consensus estimate for The Cigna Group’s current full-year earnings is $29.77 per share.

Other research analysts have also issued reports about the stock. Robert W. Baird reduced their price objective on shares of The Cigna Group from $388.00 to $362.00 and set an “outperform” rating for the company in a research note on Tuesday, April 15th. Mizuho lifted their price target on The Cigna Group from $360.00 to $384.00 and gave the company an “outperform” rating in a research report on Wednesday, April 9th. UBS Group dropped their price objective on The Cigna Group from $410.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Truist Financial raised their target price on The Cigna Group from $375.00 to $385.00 and gave the stock a “buy” rating in a research note on Friday, April 11th. Finally, Raymond James reiterated a “strong-buy” rating and set a $360.00 price target (down from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Two research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat.com, The Cigna Group presently has a consensus rating of “Buy” and a consensus target price of $378.00.

The Cigna Group Trading Down 0.5 %

Shares of The Cigna Group stock opened at $332.99 on Tuesday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The stock has a market capitalization of $91.13 billion, a P/E ratio of 27.21, a P/E/G ratio of 0.98 and a beta of 0.47. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The stock’s 50-day simple moving average is $323.77 and its 200 day simple moving average is $309.57.

The Cigna Group (NYSE:CI) last issued its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.35 by $0.39. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The firm had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. During the same period in the previous year, the company posted $6.47 earnings per share. The business’s revenue was up 14.4% on a year-over-year basis.

The Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date of this dividend is Tuesday, June 3rd. The Cigna Group’s payout ratio is currently 49.35%.

Insiders Place Their Bets

In related news, Director Elder Granger sold 2,376 shares of the stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $310.35, for a total transaction of $737,391.60. Following the completion of the sale, the director now directly owns 5,471 shares in the company, valued at $1,697,924.85. This represents a 30.28 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO David Cordani sold 26,527 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $8,173,499.24. Following the transaction, the chief executive officer now owns 127,767 shares in the company, valued at approximately $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,751 shares of company stock valued at $13,603,991. 0.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On The Cigna Group

Institutional investors have recently added to or reduced their stakes in the company. TCTC Holdings LLC purchased a new position in The Cigna Group during the 4th quarter valued at about $25,000. Collier Financial bought a new stake in shares of The Cigna Group in the 4th quarter worth approximately $32,000. ORG Wealth Partners LLC purchased a new position in shares of The Cigna Group during the fourth quarter valued at approximately $34,000. Putney Financial Group LLC bought a new position in shares of The Cigna Group during the fourth quarter valued at approximately $36,000. Finally, Compagnie Lombard Odier SCmA purchased a new stake in The Cigna Group in the fourth quarter worth $37,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.